Fertility Preservation in Young Women With Cancer

Launched by UNIVERSITY HOSPITAL, GASTHUISBERG · Aug 22, 2016

Keywords

ClinConnect Summary

This clinical trial is focused on helping young women with cancer preserve their ability to have children in the future. Researchers are studying how often this kind of fertility-preserving treatment is used, how well it works, and what happens to women long after their cancer treatment is finished. The results from women participating in this trial will be compared to those undergoing standard cancer treatments that may not include options for preserving fertility.

To be eligible for this study, participants must be young women who wish to protect their fertility while receiving cancer treatment. They will need to provide written permission to take part in the trial. Unfortunately, women with significant mental challenges that would prevent them from understanding the study cannot participate. Those who join can expect to be closely monitored during their treatment and follow-up care, allowing researchers to gather important information about both their cancer care and fertility outcomes.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Young women who want to preserve their fertility during cancer treatment. Patients need to give their signed and written informed consent to participate in the study.
• Exclusion Criteria:
• • Mentally disabled or significantly altered mental status that would prohibit the understanding and giving of informed consent